GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (CHIX:RECm) » Definitions » Inventories, Finished Goods

Recordati SpA (CHIX:RECM) Inventories, Finished Goods : €313 Mil (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Recordati SpA Inventories, Finished Goods?

Recordati SpA's quarterly finished goods stayed the same from Jun. 2024 (€0 Mil) to Sep. 2024 (€0 Mil) but then increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€313 Mil).

Recordati SpA's annual finished goods declined from Dec. 2022 (€253 Mil) to Dec. 2023 (€233 Mil) but then increased from Dec. 2023 (€233 Mil) to Dec. 2024 (€313 Mil).


Recordati SpA Inventories, Finished Goods Historical Data

The historical data trend for Recordati SpA's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Inventories, Finished Goods Chart

Recordati SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.80 117.48 253.17 232.53 312.88

Recordati SpA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 232.53 - - - 312.88

Recordati SpA Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Recordati SpA Business Description

Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines